WASHINGTON There's no shortage of interventional cardiology protocols, but when you're called to the bedside of a 58-year-old patient with 4 hours of chest pain, stage 3 lymphoma, and thrombocytopenia, the calculus of when to call the cath lab is complex and the evidence sparse. "Twenty years ago, I'd walk around and just ask oncologists: 'What's the platelet count that's dangerous?' Somehow or another, 30,000 [mm3] seems to be what I continuously hear, even to this dayeven though there's no scientific evidence for how we got to that conclusion," said Jean-Bernard Durand, MD, medical director of Cardiomyopathy Services, University of Texas MD Anderson Cancer Center, Houston Continue reading →

KIRKLAND, Wash., Feb. 25, 2020 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today announced the findings of a post hoc analysis of pooled prospectively collected data from three studies of the Carillon Mitral Contour System with a focus on 5-year survival rate and the determinants of long-term survival. The data was presented in a late-breaking trials session at the Cardiovascular Research Technologies meeting (CRT 2020) in National Harbor, MD. Continue reading →

Wavebreakmedia/Getty Images Before you try to stop a heart attack, you'll first need to make sure that the major symptoms are indicating a heart attack. "People complain of discomfort in the middle of their chest that may radiate up to their neck, to their jaw, and to their arms," says Lawrence Phillips, MD, a cardiologist and assistant professor at NYU Langone. "They may feel shortness of breath, nausea, and sweating with it." If you or someone else is experiencing these symptoms, you'll want to act fast. Continue reading →

New research from University of Alberta cardiologists suggests that treating one of the most serious types of heart attack with clot-busting drugs along with the current primary treatment may lead to better health outcomes for patients. When a patients coronary artery is completely blocked, cutting off blood to a large part of the heartwhich is an ST-segment elevation myocardial infarction, or STEMIthe primary treatment is to insert a balloon catheter into the blocked vessel to expand it and restore blood flow. Interventional cardiologist Kevin Bainey and his team reviewed data from more than 5,000 Edmonton-area patients between 2006 and 2016 who were admitted to hospital for STEMI-type heart attacks Continue reading →

2020Edition The Global Interventional Cardiology Market research report 2018 provides detailed information about the industry based on the revenue (USD MN) and volume (Units) for the forecast period 2018-2023. The Research Report provides the updated business information and industry future trends, that allows you to spot the products and end users driving Revenue growth and profit. Continue reading →

QY Research has Published Latest Trending Report on Global Interventional Cardiology Market Los Angeles, United State, The report titledGlobal Interventional Cardiology Marketis one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Interventional Cardiology market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Interventional Cardiology market. Continue reading →

NEW YORK (Reuters Health) Patients with low-flow and low-gradient aortic stenosis (LFLG-AS) who do not show improvement in mitral regurgitation after transcatheter aortic valve replacement (TAVR) face a higher risk of mortality, according to a substudy of a multi-center registry. "Some degree of mitral regurgitation, usually of functional origin, is common in patients with LFLG-AS and improves in a significant proportion after TAVR Continue reading →